In Vitro Toxicity Testing Market was valued at$18,565.2 million in 2020 and is projected to reach $59,147.6 million by 2030, growing at a CAGR of 12.0% from 2020 to 2030. In vitro is the process that helps examine harmful chemicals over the isolated part of the organism. It is used to identify hazardous chemical substances and helps detect toxicity at early stages of the development of new products, such as drugs, cosmetics, and food additives. The in vitro toxicity testing (IVTT) is mainly used for safety evaluation in drug development and also for ranking the chemicals according to their potency. The absorption, distribution, metabolism, excretion (ADME), dose response, and threshold response of the drug can also be determined by in vitro toxicity testing.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
- Helsinn Holding S.A.
- Laboratory Corporation of America Holdings
- ACACIA PHARMA GROUP PLC
- Thermo Fisher Scientific, Inc.
- Heron Therapeutics Inc
- General Electric Company
- TESARO INC.
- Catalent Inc
- AstraZeneca plc
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/1523
The In Vitro Toxicity Testing Market can be segmented based on several factors. Here are some common segmentation approaches:
By Type:
- Absorption
- Toxic Substances
- Dose
By Techniology:
- Cell Culture Technologies
- High Throughput Technologies
- Toxicogenomics
End User:
- Cosmetics and Households Products
- Pharmaceuticals Industry
- Food Industry
- Chemicals Industry
By Region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, Italy, France, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, South Korea, Rest Of Asia Pacific)
- LAMEA (Latin America, Middle East, Africa)
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/1523
𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
According to the new market research report In Vitro Toxicity Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065Due to covid-19 outbreak, there has been a significant increase in Covid-19 testing and drug research.
The research in this area is being further undertaken to understand the dynamics of the infection better, which is expected to propel the in vitro toxicology research field further.
On the other hand, we are estimating that the major share of diagnostic assays and molecular testing of Covid-19, along with personalized medicine will grow at a stable pace in the next five years.
There is a huge increase of manufacturers that have taken key steps to increase patient access to coronavirus diagnostic testing, vaccine and drug development in laboratories, hospitals, and other testing sites across the country to guide patient care and protect public health.The major factors driving the growth of this in vitro toxicity testing market are the opposition to animal testing, technological advancements, and increasing R expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market.In the toxicity endpoints and tests market, the organ toxicity segment is expected to grow at the highest CAGR during the forecast periodThe organ toxicity segment is expected to grow at the highest CAGR during the forecast period.
The growth in this segment can be attributed to factors such as the increasing focus on drug safety and consumer-product safety, along with the need to screen potential drug targets during the early stage of drug development.Based on the technologies used in the in vitro toxicology testing, the cell culture technologies segment is expected to account for the largest share of the in vitro toxicology testing marketThe cell culture technologies segment is estimated to account for the largest market share in 2018.
The large share of this segment can be attributed to the fact that it is the most preferred technique for toxicity testing, being capable of mimicking in vivo conditions.By product and service, the consumables segment is expected to account for the largest share of the in vitro toxicity testing marketThe consumables segment is estimated to account for the largest market share in 2019.
